Purpose: To report the use of directional atherectomy to treat venous in-stent restenosis (ISR) and subsequent histopathological analysis of retrieved intrastent tissue. Case Report: A 55-year-old man presented with recurrent symptoms of venous congestion following iliofemoral stenting. The stents were found to be occluded on imaging. Directional atherectomy was used to recanalize the iliofemoral venous stents, which provided significant symptom relief. Tissue retrieved from within the stent demonstrated patterns of cellular components similar to arterial ISR. At 6-month follow-up, the stents remain patent, with no evidence of further ISR. Conclusion: Directional atherectomy is a potential treatment option for iliofemoral venous ISR. The pathological process of venous ISR demonstrates cellular changes similar to arterial ISR.
NeglénPHollisKCOlivierJ, et al. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg. 2007;46:979–990.
5.
ComerotaAJOostraCFayadZ, et al. A histological and functional description of the tissue causing chronic postthrombotic venous obstruction. Thromb Res. 2015;135:882–887.
6.
SchmidtJ-OChristensenJKHoulindKC.Calcified in-stent restenosis in a venous stent. J Vasc Surg Cases. 2015;1:261–263.
7.
SixtSCancinoOGCTreszlA, et al. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries. J Vasc Surg. 2013;58:682–686.
8.
Van Den BergJCPedrottiMCanevasciniR, et al. Endovascular treatment of in-stent restenosis using excimer laser angioplasty and drug eluting balloons. J Cardiovasc Surg. 2012;53:215–222.
9.
VirgaVStabileEBiaminoG, et al. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up. JACC Cardiovasc Interv. 2014;7:411–415.
10.
KokkinidisDGHossainPJawaidO, et al. Laser atherectomy combined with drug-coated balloon angioplasty is associated with improved 1-year outcomes for treatment of femoropopliteal in-stent restenosis. J Endovasc Ther. 2018;25:81–88.
11.
BennettMRO’SullivanM.Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy. Pharmacol Ther. 2001;91:149–166.
